These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9495263

  • 1. Renoprotective effects of felodipine and/or enalapril in spontaneously hypertensive rats with and without L-NAME.
    Francischetti A, Ono H, Frohlich ED.
    Hypertension; 1998 Mar; 31(3):795-801. PubMed ID: 9495263
    [Abstract] [Full Text] [Related]

  • 2. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
    Ono H, Ono Y, Frohlich ED.
    Hypertension; 1996 Feb; 27(2):176-83. PubMed ID: 8567038
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats.
    Nakamura Y, Ono H, Frohlich ED.
    Hypertension; 1999 Aug; 34(2):273-8. PubMed ID: 10454453
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats.
    Nakamura Y, Ono H, Zhou X, Frohlich ED.
    Hypertension; 2001 May; 37(5):1262-7. PubMed ID: 11358938
    [Abstract] [Full Text] [Related]

  • 5. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X, Matavelli LC, Ono H, Frohlich ED.
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
    [Abstract] [Full Text] [Related]

  • 6. N- and L-type calcium channel antagonist improves glomerular dynamics, reverses severe nephrosclerosis, and inhibits apoptosis and proliferation in an l-NAME/SHR model.
    Zhou X, Ono H, Ono Y, Frohlich ED.
    J Hypertens; 2002 May; 20(5):993-1000. PubMed ID: 12011661
    [Abstract] [Full Text] [Related]

  • 7. Hydrochlorothiazide exacerbates nitric oxide-blockade nephrosclerosis with glomerular hypertension in spontaneously hypertensive rats.
    Ono Y, Ono H, Frohlich ED.
    J Hypertens; 1996 Jul; 14(7):823-8. PubMed ID: 8818920
    [Abstract] [Full Text] [Related]

  • 8. Pharmacologic agents on cardiovascular mass, coronary dynamics and collagen in aged spontaneously hypertensive rats.
    Susic D, Varagic J, Frohlich ED.
    J Hypertens; 1999 Aug; 17(8):1209-15. PubMed ID: 10466478
    [Abstract] [Full Text] [Related]

  • 9. Influence of irbesartan and enalapril on changes of renal function associated with the established phase of l-NAME hypertension.
    Jover B, Herizi A, Casellas D, Mimran A.
    J Hypertens; 2001 Nov; 19(11):2039-46. PubMed ID: 11677370
    [Abstract] [Full Text] [Related]

  • 10. Renoprotective effects of omapatrilat are mediated partially by bradykinin.
    Zhou X, Ono H, Ono Y, Frohlich ED.
    Am J Nephrol; 2003 Nov; 23(4):214-21. PubMed ID: 12789027
    [Abstract] [Full Text] [Related]

  • 11. Effect of the antihypertensive drug enalapril on oxidative stress markers and antioxidant enzymes in kidney of spontaneously hypertensive rat.
    Chandran G, Sirajudeen KN, Yusoff NS, Swamy M, Samarendra MS.
    Oxid Med Cell Longev; 2014 Nov; 2014():608512. PubMed ID: 25254079
    [Abstract] [Full Text] [Related]

  • 12. Mibefradil prevents L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
    Qiu C, Bruneval P, Roeckel A, Heudes D, Duong Van Huyen JP, Roux S.
    J Hypertens; 1999 Oct; 17(10):1489-95. PubMed ID: 10526911
    [Abstract] [Full Text] [Related]

  • 13. Short-term ACE inhibition confers long-term protection against target organ damage.
    Hale TM, Robertson SJ, Burns KD, deBlois D.
    Hypertens Res; 2012 Jun; 35(6):604-10. PubMed ID: 22318205
    [Abstract] [Full Text] [Related]

  • 14. Protection against L-NAME-induced reduction in cardiac output persists even after cessation of angiotensin-converting enzyme inhibitor treatment.
    Biwer LA, Broderick TL, Xu H, Carroll C, Hale TM.
    Acta Physiol (Oxf); 2013 Jan; 207(1):156-65. PubMed ID: 22834875
    [Abstract] [Full Text] [Related]

  • 15. Kidney adaptation in nitric oxide-deficient Wistar and spontaneously hypertensive rats.
    Pereira LM, Almeida JR, Mandarim-de-Lacerda CA.
    Life Sci; 2004 Jan 30; 74(11):1375-86. PubMed ID: 14706568
    [Abstract] [Full Text] [Related]

  • 16. Imidapril improves L-NAME-exacerbated nephrosclerosis with TGF-beta 1 inhibition in spontaneously hypertensive rats.
    Ono H, Saitoh M, Ono Y, Ishimitu T, Matsuoka H.
    J Hypertens; 2004 Jul 30; 22(7):1389-95. PubMed ID: 15201556
    [Abstract] [Full Text] [Related]

  • 17. Nitric oxide synthase inhibition in spontaneously hypertensive rats. Systemic, renal, and glomerular hemodynamics.
    Ono H, Ono Y, Frohlich ED.
    Hypertension; 1995 Aug 30; 26(2):249-55. PubMed ID: 7543452
    [Abstract] [Full Text] [Related]

  • 18. Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalapril.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2000 Aug 30; 27(8):642-6. PubMed ID: 10901398
    [Abstract] [Full Text] [Related]

  • 19. Combination of low-dose valsartan and enalapril improves endothelial dysfunction and coronary reserve in Nomega-nitro-L-arginine methyl ester-treated spontaneously hypertensive rats.
    de Gasparo M, Hess P, Clozel M, Persohn E, Roman D, Germann PG, Clozel JP, Webb RL.
    J Cardiovasc Pharmacol; 2002 Nov 30; 40(5):789-800. PubMed ID: 12409988
    [Abstract] [Full Text] [Related]

  • 20. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK, Drew GM.
    Br J Pharmacol; 1997 Dec 30; 122(7):1385-94. PubMed ID: 9421286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.